Holzer, M.; Ziegler, S.; Albrecht, B.; Kronenberger, B.; Kaul, A.; Bartenschlager, R.; Kattner, L.; Klein, C.D.; Hartmann, R.W.
Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization. Molecules 2008, 13, 1081-1110.
https://doi.org/10.3390/molecules13051081
AMA Style
Holzer M, Ziegler S, Albrecht B, Kronenberger B, Kaul A, Bartenschlager R, Kattner L, Klein CD, Hartmann RW.
Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization. Molecules. 2008; 13(5):1081-1110.
https://doi.org/10.3390/molecules13051081
Chicago/Turabian Style
Holzer, Marcel, Sigrid Ziegler, Beatrice Albrecht, Bernd Kronenberger, Artur Kaul, Ralf Bartenschlager, Lars Kattner, Christian D. Klein, and Rolf W. Hartmann.
2008. "Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization" Molecules 13, no. 5: 1081-1110.
https://doi.org/10.3390/molecules13051081
APA Style
Holzer, M., Ziegler, S., Albrecht, B., Kronenberger, B., Kaul, A., Bartenschlager, R., Kattner, L., Klein, C. D., & Hartmann, R. W.
(2008). Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization. Molecules, 13(5), 1081-1110.
https://doi.org/10.3390/molecules13051081
